Forvis Wealth Advisors, LLC Dexcom Inc Transaction History

Forvis Wealth Advisors, LLC

$4.41 Billion
Q2 2025

A detailed history of Forvis Wealth Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Forvis Wealth Advisors, LLC holds 15,713 shares of DXCM stock, worth $1.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

15,713

Previous 17,481 10.11%

Holding current value

$1.1 Million

Previous $1.19 Million 14.92%

% of portfolio

0.03%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	SELL	$59.83 - $87.57 $105,779 - $154,823	-1,768 Reduced 10.11%	15,713 $1.37 Million
Q4 2024 Feb 03, 2025	BUY	$65.68 - $81.01 $7,750 - $9,559	118 Added 0.68%	17,481 $1.36 Million
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $43,520 - $78,920	680 Added 4.08%	17,363 $1.16 Million
Q2 2024 Aug 09, 2024	SELL	$110.31 - $140.45 $551 - $702	-5 Reduced 0.03%	16,683 $1.89 Million
Q1 2024 Apr 19, 2024	BUY	$114.22 - $140.1 $35,065 - $43,010	307 Added 1.87%	16,688 $2.31 Million
Q4 2023 Jan 11, 2024	BUY	$75.49 - $124.16 $8,303 - $13,657	110 Added 0.68%	16,381 $2.03 Million
Q3 2023 Oct 25, 2023	SELL	$86.06 - $137.93 $1,463 - $2,344	-17 Reduced 0.1%	16,271 $1.52 Million
Q1 2023 Apr 26, 2023	BUY	$104.0 - $122.92 $208 - $245	2 Added 0.01%	16,288 $1.89 Million
Q4 2022 Feb 02, 2023	BUY	$84.98 - $122.67 $2,124 - $3,066	25 Added 0.15%	16,286 $1.84 Million
Q3 2022 Oct 13, 2022	SELL	$76.35 - $94.18 $5,115 - $6,310	-67 Reduced 0.41%	16,261 $1.31 Million
Q2 2022 Jul 22, 2022	BUY	$67.99 - $132.89 $833,421 - $1.63 Million	12,258 Added 301.18%	16,328 $1.22 Million
Q4 2021 Jan 14, 2022	SELL	$129.87 - $162.82 $129 - $162	-1 Reduced 0.02%	4,070 $2.19 Million
Q3 2021 Oct 14, 2021	BUY	$106.71 - $143.18 $213 - $286	2 Added 0.05%	4,071 $2.23 Million
Q2 2021 Jul 14, 2021	SELL	$80.99 - $107.93 $161 - $215	-2 Reduced 0.05%	4,069 $1.74 Million
Q1 2021 Apr 23, 2021	SELL	$84.79 - $104.74 $13,820 - $17,072	-163 Reduced 3.85%	4,071 $1.46 Million
Q4 2020 Jan 22, 2021	SELL	$78.0 - $104.5 $3,744 - $5,016	-48 Reduced 1.12%	4,234 $1.57 Million
Q3 2020 Nov 05, 2020	BUY	$95.51 - $112.95 $3,056 - $3,614	32 Added 0.75%	4,282 $1.77 Million
Q2 2020 Jul 15, 2020	BUY	$62.68 - $105.34 $2,945 - $4,950	47 Added 1.12%	4,250 $1.72 Million
Q1 2020 Apr 10, 2020	SELL	$47.79 - $75.63 $143 - $226	-3 Reduced 0.07%	4,203 $1.13 Million
Q4 2019 Jan 13, 2020	BUY	$36.62 - $57.29 $2,087 - $3,265	57 Added 1.37%	4,206 $920,000
Q2 2019 Jul 10, 2019	BUY	$27.84 - $38.92 $111 - $155	4 Added 0.1%	4,149 $622,000
Q4 2018 Jan 15, 2019	SELL	$26.99 - $37.37 $512 - $710	-19 Reduced 0.46%	4,145 $497,000
Q2 2018 Jul 13, 2018	SELL	$17.54 - $25.22 $1,140 - $1,639	-65 Reduced 1.54%	4,164 $395,000
Q1 2018 May 25, 2018	BUY	$13.06 - $18.54 $848 - $1,205	65 Added 1.56%	4,229 $314,000
Q1 2018 Apr 20, 2018	BUY	$13.06 - $18.54 $130 - $185	10 Added 0.24%	4,164 $306,000
Q4 2017 Jan 18, 2018	BUY	$11.12 - $15.38 $611 - $845	55 Added 1.34%	4,154 $238,000
Q3 2017 Oct 13, 2017	BUY	$11.36 - $18.98 $46,564 - $77,799	4,099	4,099 $201,000

Others Institutions Holding DXCM

# of Institutions

1,104

Shares Held

369M

Call Options Held

5.32M

Put Options Held

5.18M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forvis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forvis Wealth Advisors, LLC with notifications on news.

Account

Forvis Wealth Advisors, LLC Dexcom Inc Transaction History